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ABSTRACT
Objective To explore if newborns in the second pregnancy 
following a previous caesarean delivery (CD) have higher 
risk of perinatal mortality or cerebral palsy than newborns 
in pregnancies following a previous vaginal delivery (VD).
Design Cohort study with information from the Medical 
Birth Registry of Norway and the Cerebral Palsy Registry 
of Norway.
Setting Births in Norway.
Participants 294 598 women with their first and second 
singleton delivery during 1996–2015.
Main outcome measures Stillbirth, perinatal mortality, 
neonatal mortality and cerebral palsy.
Results Among 294 598 included women, 42 962 (15%) 
had a CD in their first pregnancy while 251 636 (85%) 
had a VD. Compared with the second delivery of mothers 
with a previous VD, the adjusted OR (adjOR), for stillbirth in 
the second pregnancy following a previous CD was 1.45, 
95% CI 1.22 to 1.73; for perinatal death the adjOR was 
1.42 (1.22 to 1.73) and for neonatal death 1.13 (0.86 to 
1.49). Among children who survived the neonatal period, 
the adjOR for cerebral palsy was 1.27 (0.99 to 1.64). 
Secondary outcomes, including small for gestational 
age, preterm and very preterm birth, uterine rupture and 
placental complications (eg, postpartum haemorrhage 
and pre- eclampsia) were more frequent in the subsequent 
pregnancy following a previous CD compared with a 
previous VD, in particular for uterine rupture adjOR 86.7 
(48.2 to 156.1). Adjustment for potential confounders 
attenuated the ORs somewhat, but the excess risk in the 
second pregnancy persisted for all outcomes.
Conclusion A previous CD was in this study associated 
with increased risk for stillbirth and perinatal death 
compared with a previous VD. Although less robust, we 
also found that a previous CD was associated with a 
slightly increased risk of cerebral palsy among children 
surviving the neonatal period. The aetiology behind these 
associations needs further investigation.
INTRODUCTION
Between year 2000 and 2015, the number of 
caesarean deliveries (CD) increased from 16 to 
29.7 million deliveries worldwide.1 Moreover, 
in 2008, WHO estimated that 6.2 million not 
medically indicated CDs were performed each 
year.2 The ‘ideal’ CD rate has been debated 
for many years, and different studies have 
argued that a higher rate than 15% would not 
improve maternal and neonatal outcomes,3–5 
while others have suggested national CD rate 
up to 19%.6 However, many middle- income 
and high- income countries have CD rates of 
30%–50%.7 Although the risk for severe acute 
complications of CD is low in these countries,8 
concerns regarding long- term complications, 
both for the mother and her child have been 
raised, also in subsequent pregnancy.9 10
In Norway, a country with a CD rate of 
16%, approximately 65% of the total number 
are emergency CDs.11 However, in deliveries 
when planned CD is recommended to prevent 
potentially adverse outcomes of vaginal 
delivery (VD), these advantages should be 
weighed against potential long- term compli-
cations, including those in later pregnancies. 
This is particularly important when the abso-
lute risk for acute complications during VD is 
low, such as in breech VD.12 Studies have also 
reported higher risk for placental compli-
cations and uterine rupture in pregnancies 
following a previous CD.10 13 14 These compli-
cations are also associated with higher risk 
for delayed neurodevelopment and cerebral 
Strengths and limitations of this study
 ► Prospectively recording of high- quality data in the 
two national registers.
 ► Large number of births.
 ► Misclassification may occur for some of the clinical 
outcomes.
 ► Limited ability to address explanatory factors.
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palsy in the offspring.15 16A balanced information on 
potential long- term consequences of CD is even more 
important when the mother requests her baby to be deliv-
ered by CD, but where medical evidence to support this 
choice is limited.17
On this background, the main aim of the present 
study was to explore if offspring in deliveries following a 
previous CD, have higher risk for perinatal death or cere-
bral palsy than offspring where the mother had a previous 
VD. As secondary outcomes, we also assessed the risks for 
placental complications, uterine rupture, preterm birth, 
fetal growth restriction and neonatal morbidity in the 
offspring following an earlier CD compared with those 
following a previous VD.
METHODS
In this population- based cohort study, including all births 
in Norway between 1996 and 2015 and information 
regarding pregnancy, delivery and the neonatal period 
was retrieved from the Medical Birth Registry of Norway 
(MBRN). This information was combined with informa-
tion on a diagnosis of cerebral palsy recorded in the Cere-
bral palsy Registry of Norway (CPRN). The unique 11- digit 
personal identification number for every Norwegian 
citizen was used to link information from the two regis-
ters and made it possible to follow the women throughout 
all her pregnancies. Registration in the MBRN has been 
compulsory since 1967 with prospectively recorded infor-
mation during pregnancy and at birth, including demo-
graphic variables, information on maternal health before 
and during pregnancy, interventions and complications 
during pregnancies, delivery and neonatal outcomes 
(including stillbirth). The CPRN is an informed consent- 
based national quality register established in 2006 and 
aims to record detailed information on all children with 
cerebral palsy born in Norway since 1996. Paediatricians 
at the neurohabilitation centres in Norway complete the 
information of each child using a standardised form. A 
validation study indicated that ~80% of the children with 
cerebral palsy born in Norway in 1996–2007 had detailed 
information in the CPRN.18 Later validations have 
suggested that the completeness is around 90% in recent 
years (annual reports of the CPRN).
Eligible for inclusion in this population- based study was 
women who delivered their first and second singleton 
child in Norway during 1996–2015. We excluded offspring 
who were born before 22 completed weeks of gestation 
and had a birth weight below 500 g. The offsprings were 
linked to their mothers by means of the national identi-
fication numbers, yielding maternal sibship files with the 
mother as the observation unit.
Study variables
The exposure variable was CD in the first pregnancy, 
regardless of whether this was emergency or planned. 
The reference group comprised mothers who delivered 
their first child vaginally (VD).
The predefined main outcome measures were stillbirth 
(antepartum and intrapartum and those with unspeci-
fied timing of death), perinatal mortality (stillbirth and 
deaths during first week of life), early neonatal mortality 
(deaths during first week of life), neonatal mortality 
(deaths during first 28 days of life) and cerebral palsy. 
In the CPRN, the diagnosis cerebral palsy is confirmed 
at 5 years of age according to the definition and classifi-
cation proposed by the Surveillance of Cerebral Palsy in 
Europe.19
Secondary outcomes were preterm birth, evidence of 
fetal growth restriction, uterine rupture and placental 
complications such as placenta previa, placental abrup-
tion, abnormal invasive placenta, pre- eclampsia and post-
partum haemorrhage. Preterm birth was defined as a birth 
before 37 weeks, and very preterm birth as a birth before 
32 completed weeks of gestation. Evidence of fetal growth 
restriction was assessed by the proxy small for gestational 
age (SGA) defined by a birth weight below—2 SD of the 
population mean weight for GA, adjusted for sex.20
Other variables extracted from the MBRN were 
maternal and pregnancy- related disorders such as preges-
tational diabetes, gestational diabetes and pre- eclampsia. 
For the purpose of the present study, we included gesta-
tional diabetes, and diabetes mellitus type 1 and 2 in 
the composite variable ‘diabetes’, while pre- eclampsia 
included mild, severe and unspecified pre- eclampsia, 
in addition to eclampsia and haemolysis, elevated liver 
enzymes, low platelets. Maternal age, birth year, smoking 
and congenital anomalies were also extracted. Informa-
tion on smoking, recorded in the MBRN since December 
1998, is based on information from ‘the antenatal chart’, 
a standardised form intended for clinical use, carried 
by the mother to each antenatal visit and completed 
by midwives and doctors responsible for the antenatal 
care. The mother is asked about smoking habits (daily 
smoking, occasionally or not at all) at first antenatal visit 
and at the end of the pregnancy. However, in contrast to 
all other variables registered in the MBRN, the mother 
may decline that her information on smoking is reported 
to the MBRN. Thus, information on smoking is missing 
for a subsample of mothers (around 12% in 1999–2000, 
nearly 20% in 2004–2007 and decreasing to less than 10% 
since 2015). For those with smoking information regis-
tered, we defined smokers as mothers who indicated that 
they smoked daily or occasionally either at the beginning 
or at the end of the pregnancy or both. Non- smokers were 
mothers who responded that they did not smoke during 
the pregnancy.
Gestational age was based on ultrasound examination 
before 20 weeks of gestation in 84% of the pregnant 
women, while in the remaining it was calculated from the 
last menstrual period.
Statistical analyses
Differences in proportions between groups were analysed 
using the Χ2 test, and differences in means for continuous 
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variables were analysed using the Student’s t- test not assuming 
equal variances.
Logistic regression analyses were used to calculate 
crude and adjusted ORs (OR) with 95% CIs for adverse 
outcomes of the second delivery following a CD in the 
first, compared with the outcomes of second deliveries 
following a first VD.
Potential confounders included in the multivariable anal-
yses were selected based on availability, a priori knowledge 
and directed acyclic graphs methodology.21 These variables 
included pregnancy- related disorders (such as diabetes and 
pre- eclampsia), maternal age, birth year, SGA and congenital 
anomalies all recorded at the first delivery.
Since there is a risk of recurrence of adverse outcomes, 
such as stillbirth, perinatal death, preterm birth, fetal growth 
restriction and pre- eclampsia from one delivery to the 
next,22–24 we included complications in the first pregnancy 
that were defined as an adverse outcome in the second, as 
potential confounders. These complications may also affect 
the choice of mode of delivery in the first pregnancy, leading 
to potential confounding by indication, partly adjusted for 
in the logistic regression analyses described above. In addi-
tion, we also assessed confounding by indication in stratified 
analyses within subgroups of pregnancies with high and low 
risk for adverse outcomes.25 The high- risk group comprised 
women with any complication in the first pregnancy that 
in the second pregnancy were considered as primary or 
secondary outcomes (stillbirth, perinatal mortality, neonatal 
mortality, SGA, placenta previa, postpartum haemorrhage, 
uterine rupture, placental abruption, preterm delivery 
and pre- eclampsia). The low- risk group included mothers 
without any of the specified primary or secondary outcomes 
in the first delivery, and where the first infant was born at 
term.
In separate analyses, maternal smoking was explored 
as a potential additional confounder in the population of 
mothers who had available information on smoking, with 
first deliveries from 1999.
Moreover, the birth intervals between pregnancies are 
likely to be shorter in mothers with a perinatal loss than 
in mothers whose first baby survived.26 Mothers with a first 
delivery towards the end of the study period will have shorter 
interpregnancy intervals, and therefore, be more likely to 
have a first perinatal loss, and thus at increased risk for a 
recurrent second loss. In order to assess this possible bias, we 
performed a sensitivity analysis where we excluded women 
who had their first birth in 2012 or later, since these women 
had interpregnancy interval less than 4 years. Analyses from 
the MBRN show that 95% of women with two or more births, 
have their second child within 7 years following the first.27 
IBM SPSS Statistics V.25 was used for data analyses.
Patient involvement
Patients were not involved in setting the research question or 
the outcome measures nor were they involved in the design 
and implementation of the study. There are currently no 
plans to involve patients in dissemination.
RESULTS
During the study period, 454 031 mothers gave birth to a 
singleton as their first birth, but 159 433 had only one delivery. 
Among the remaining 294 598 mothers, 42 962 (15%) had 
a CD in their first pregnancy while 251 636 (85%) had a VD 
(figure 1).
Characteristics of the mothers and their babies, as well as 
adverse outcomes in the first pregnancy when mothers had 
a caesarean or VD are shown in table 1. The table shows 
that intrapartum stillbirth and neonatal loss occurred more 
frequently, whereas antepartum and total stillbirth occurred 
less frequently in the group of mothers with CD than mothers 
with a VD. Perinatal mortality did not differ between the two 
groups. A higher proportion of mothers in the CD group 
than in the VD group had pre- eclampsia and diabetes and 
more children were SGA, had congenital anomalies and 
were later diagnosed with cerebral palsy (table 1).
In their second delivery, approximately half of the women 
with a previous CD also had CD in their subsequent preg-
nancy, compared with 6% among those with a previous VD 
(table 2). Gestational age and mean birth weight were slightly 
lower and congenital anomalies, Apgar scores below 7 after 5 
min and being transferred to the NICU were more common 
in the group with a previous CD (table 2).
When adjusting for potential confounders, the second 
infant of mothers with a previous CD had higher odds 
for antepartum and intrapartum stillbirth, total stillbirth 
and perinatal death compared with the second infant of a 
mother with a previous VD (table 3). The adjusted OR for 
early neonatal mortality was 1.27 (95% CI 0.92 to 1.73), for 
Figure 1 Flow chart of the study population. Only the first 
(exposure) and second (outcome) delivery of these women 
were included in the study.
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Table 1 Maternal and infant characteristics and adverse 
outcomes in the first pregnancy of 42 962 women who had 
a caesarean and 251 636 women who had a vaginal delivery 
(VD) during 1996–2015
CD VD
Age, mean (SD) 27.8 (4.7) 26.5 (4.5)
Smoking, N (%)
  Information about 
smoking in the 
MBRN
29 229 (68.0) 170 040 (67.6)
  Smoked during 
pregnancy
4571 (15.6)* 27 273 (16.0)*
Pre- eclampsia N (%) 5348 (12.4) 9346 (3.7)
Diabetes, N (%) 1366 (3.2) 2977 (1.2)
Placenta previa N (%) 474 (1.1) 52 (0.02)
Placenta abruption N 
(%)
865 (2.0) 258 (0.1)
Uterine rupture N (%) 5 (0.01) 5 (0.002)
Start of delivery, N (%)
  Spontaneous 18 568 (43.2) 215 243 (85.5)
  Induced 10 626 (24.7) 36 393 (14.5)
  Caesarean delivery 
(CD)
13 768 (33.0) 0
Gestational age at 
birth in weeks, mean 
(SD)
39.0 (2.9) 39.6 (1.9)
Birth weight in grams, 
mean (SD)
3401 (810) 3477 (524)
Sex, N (%)
  Female 19 597 (46.0) 123 230 (49.0)
SGA†, N (%) 1995 (5.0) 4823 (2.0)
Congenital anomalies, 
N (%)
3004 (7.0) 10 386 (4.1)
Total stillbirth, N (%) 110 (0.3) 1408 (0.6)
Antepartum stillbirth, 
N (%)
55 (0.1) 1039 (0.4)
Intrapartum stillbirth, 
N (%)
28 (0.1) 102 (0.04)
Perinatal mortality, N 
(%)
301 (0.7) 1714 (0.7)
Early neonatal 
mortality, N (%)
191 (0.4) 306 (0.1)
Neonatal mortality, N 
(%)
262 (0.6) 399 (0.2)
Cerebral palsy, N (%) 189 (0.4) 350 (0.1)
Apgar score after five min‡, N (%)
  0–3 406 (0.9) 1662 (0.7)
  4–6 2314 (5.4) 5972 (2.3)
  7–10 40 142 (93.7) 243 221 (97.0)
Transferred NICU, N (%)
  Yes 8965 (26.0) 18 971 (10.0)
Continued
CD VD
*Percentage of mothers with information on smoking (available in 
the MBRN since 1999).
†971 (2.3%) deliveries with missing information about SGA in the 
CD group and 5280 (2.1%) in the VD group.
‡100 (0.2%) deliveries with missing information about Apgar score 
in the CD group and 781 (0.3%) in the VD group.
MBRN, Medical Birth Registry of Norway; NICU, neonatal intensive 
care unit; SGA, small for gestational age.
Table 1 Continued
Table 2 Maternal and infant characteristics, including 
mode of delivery and adverse outcomes in the second 
pregnancy of 42 962 who had a caesarean and 251 636 who 
had a vaginal delivery in their first pregnancy (CD vs VD) 
during 1996–2015
Previous CD Previous VD P value
Mothers age in 
years, mean (SD)
31.1 (4.6) 29.9 (4.4) <0.001
Diabetes, N (%) 2095 (4.9) 4834 (1.9) <0.001
Start of delivery, N (%)
  Spontaneous 22 707 (53.0) 211 165 (84.0)
  Induced 7179 (17.0) 30 895 (12.0) <0.001
  CD 13 074 (30.0) 9570 (4.0)
Mode of delivery*, N (%)
  Vaginal delivery 20 826 (48.0) 235 372 (94.0) <0.001
  CD 22 136 (52.0) 16 264 (6.0)
Gestational age at 
birth in weeks mean 
(SD)
39.1 (2.0) 39.5 (1.7) <0.001
Birth weight in 
grams mean (SD)
3577 (613) 3630 (541) <0.001
Congenital 
anomalies, N (%)
2007 (4.7) 9537 (3.8) <0.001
Sex†, N (%)
  Female 20 958 (49.0) 122 307 (49.0) 0.50
Apgar score after 5 min‡, N (%)
  0–3 292 (1.0) 1048 (0.4)
  4–6 1196 (3.0) 2955 (1.2) <0.001
  7–10 41 407 (96.0) 247 028 (98.4)
Transferred NICU, N (%)
  Yes 5424 (13.0) 16 502 (7.0) <0.001
*2 (0.005%) deliveries with missing information about start of 
delivery in the previous CD group and 6 (0.002%) in the previous 
VD group.
†12 (0.005%) deliveries with missing information about sex in the 
previous VD group.
‡67 (0.16%) deliveries with missing information about Apgar score 
in the previous CD group and 605 (0.24%) in the previous VD 
group.
CD, caesarean delivery; NICU, neonatal intensive care unit; VD, 
vaginal delivery.
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neonatal mortality the OR was 1.13 (95% CI 0.86 to 1.49) 
and for cerebral palsy OR was 1.27 (95% CI 0.99 to 1.64) 
(table 3).
When these associations were studied among women 
with high (n=78 056) and low (n=211 313) risk for adverse 
outcomes, the results were essentially the same as in the total 
study population (data are not shown).
All secondary outcomes, except abnormal invasive 
placenta, were more frequent in the subsequent preg-
nancy of women with a previous CD than among those 
with a previous VD (table 4). Most of these associations 
were attenuated in multivariable analyses, but the 
main findings persisted.
In the subsample of 199 269 women where informa-
tion about smoking was available (68% of the total study 
population), the results regarding antepartum and intra-
partum stillbirth, overall stillbirth, perinatal early and 
neonatal mortality persisted, but were slightly attenuated 
in the multivariable analyses (see online supplemen-
tary table 1). The crude OR for cerebral palsy was also 
unchanged but was reduced in the multivariable analyses 
to 1.23 (95% CI 0.90 to 1.67). However, adding smoking 
as a potential confounder to the other confounders did 
not change the adjusted OR neither for primary nor 
for the secondary outcomes (see online supplementary 
tables 1 and 2)
In the sensitivity analyses excluding women who had 
their first birth in 2012 or later (leaving 274 041 women 
for analysis), the results were nearly identical to the results 
in the total population. In this subsample, 39 812 (15%) 
had a CD in their first pregnancy and 234 229 (85%) had 
a VD (see online supplementary tables 3 and 4).
DISCUSSION
In this population- based cohort study in Norway, we found 
increased risk for stillbirth, perinatal death and cerebral 
palsy in the second pregnancy of mothers who had a CD 
in their first pregnancy, compared with mothers who had 
a VD in their first pregnancy. In contrast we did not find 
a higher risk for neonatal mortality, although there was a 
trend towards increased risk for early neonatal mortality. 
Also, growth restriction, preterm delivery, pre- eclampsia, 
placental complications, postpartum haemorrhage and 
especially uterine rupture were increased in pregnancies 
following a CD.
Strength and limitations
The strength of this study is the large number of births 
based on mandatory registration and thus minimal risk of 
selection bias. The prospectively collected data from the 
MBRN and the CPRN, and the ability to link births to their 
mothers by the identification numbers enabled complete 
analyses of the first and second births to all mothers 
giving birth in 1996–2015. We restricted the analyses 
to singletons, since both CD and the studied outcomes 
are more frequent in multiple pregnancies. Moreover, 
the main findings persisted when adjusted for poten-
tial confounders in multivariable analyses, and when we 
assessed confounding by indication in analyses restricted 
to mothers with high and low risk of adverse outcomes. In 
these latter analyses, the main findings persisted in both 
groups, suggesting that confounding by indication was 
less likely. Finally, in the subpopulation with information 
on smoking, the main results also persisted.
A potential selection bias of the study population may 
arise from the fact that women with a perinatal loss in 
their first pregnancy tend to proceed to their second 
pregnancy earlier than women without such an event, 
Table 3 OR with 95% CIs for adverse outcomes in the 
second pregnancy of 42 962 mothers who had a caesarean 
delivery (CD) in the first pregnancy compared with 251 636 
mothers who had a previous vaginal delivery (VD
1st birth 2nd birth




CD 1st N (%) 128 (0.3) 1.44 (1.19 to 
1.75)
1.33 (1.08 to 
1.63)
VD 1st N (%) 520 (0.2) 1.0 (ref) 1.0 (ref)
  Intrapartum stillbirth
CD 1st N (%) 14 (0.03) 1.58 (0.87 to 
2.85)
1.84 (1.00 to 
3.38)
VD 1st N (%) 52 (0.02) 1.0 (ref) 1.0 (ref)
  Stillbirth (total)†
CD 1st N (%) 179 (0.4) 1.52 (1.29 to 
1.79)
1.45 (1.22 to 
1.73)
VD 1st N (%) 693 (0.3) 1.0 (ref) 1.0 (ref)
  Perinatal mortality
CD 1st N (%) 231 (0.5) 1.47 (1.27 to 
1.70)
1.42 (1.22 to 
1.65)
VD 1st N (%) 921 (0.4) 1.0 (ref) 1.0 (ref)
  Early neonatal mortality
CD 1st N (%) 52 (0.1) 1.34 (0.99 to 
1.81)
1.27 (0.92 to 
1.73)
VD 1st N (%) 228 (0.1) 1.0 (ref) 1.0 (ref)
  Neonatal mortality
CD 1st N (%) 68 (0.2) 1.24 (0.95 to 
1.61)
1.13 (0.86 to 
1.49)
VD 1st N (%) 321 (0.1) 1.0 (ref) 1.0 (ref)
  Cerebral palsy
CD 1st N (%) 83 (0.2) 1.44 (1.13 to 
1.83)
1.27 (0.99 to 
1.64)
VD 1st N (%) 338 (0.1) 1.0 (ref) 1.0 (ref)
Singleton deliveries during 1996–2015.
*Adjusted for maternal age, birth year, pregnancy- related disorders 
(pre- eclampsia and diabetes), SGA, congenital anomalies, uterine 
rupture, placenta previa, placental abruption in first pregnancy and 
the studied outcome in the first pregnancy.
†including stillbirths with unknown timing of death.
SGA, small for gestational age.
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thereby artificially increasing the proportion of women 
with losses in their second pregnancy (due to the known 
recurrence risk of perinatal losses). Since the implications 
of this selection bias is unclear, we performed sensitivity 
analyses where we excluded women who had their first 
birth in 2012 or later, and hence had an interpregnancy 
interval shorter than 4 years. Moreover, in the population 
born after 2012 there may be some underreporting of 
cases with cerebral palsy, since this diagnosis is reported 
to the CPRN at age 5 years, and since there may be some 
delay in the registration. Nonetheless, all results were 
essentially unchanged.
Other limitations of this study are related to potential 
misclassification of both exposure and outcome. The 
data on mortality and delivery mode are variables with 
high quality and are unlikely to be misclassified.28 For 
the secondary outcomes, both pre- eclampsia, SGA and 
preterm delivery are variables with high quality,29 while 
the validity for placenta previa and placental abruption 
has not been studied. In addition, inconsistent defini-
tions may have led to some misclassification of uterine 
rupture and abnormal invasive placenta.30
Further limitations are related to unmeasured 
confounders, as well as to potential confounders with 
limited available data, such as body mass index and weight 
change during the pregnancy.
Comparison with other studies
Our findings regarding excess risk for stillbirth in subse-
quent pregnancies after a previous CD is consistent with 
Table 4 OR with 95% CIs for adverse secondary outcomes in the second pregnancy of 42 962 mothers who had a caesarean 
delivery (CD) in the first pregnancy compared with 251 636 mothers who had a previous vaginal delivery (VD)
1st birth 2nd birth
  Small for gestational age* Crude OR (95% CI) Adj OR (95% CI)†
CD 1st N (%) 636 (1.5) 1.63 (1.49 to 1.78) 1.32 (1.20 to 1.45)
VD 1st N (%) 2295 (0.9) 1.0 (ref) 1.0 (ref)
  Preterm birth‡
CD 1st N (%) 2647 (6.2) 1.72 (1.64 to 1.80) 1.18 (1.12 to 1.24)
VD 1st N (%) 9254 (3.7) 1.0 (ref) 1.0 (ref)
  Very preterm birth‡
CD 1st N (%) 570 (1.3) 1.97 (1.79 to 2.17) 1.29 (1.16 to 1.44)
VD 1st N (%) 1703 (0.7) 1.0 (ref) 1.0 (ref)
  Postpartum haemorrhage
CD 1st N (%) 12 232 (28) 2.76 (2.70 to 2.83) 2.32 (2.26 to 2.38)
VD 1st N (%) 31 705 (12) 1.0 (ref) 1.0 (ref)
  Placenta previa
CD 1st N (%) 292 (0.7) 2.60 (2.27 to 2.99) 2.33 (2.01 to 2.70)
VD 1st N (%) 660 (0.3) 1.0 (ref) 1.0 (ref)
  Placental abruption
CD 1st N (%) 282 (0.7) 2.48 (2.16 to 2.86) 2.14 (1.84 to 2.49)
VD 1st N (%) 668 (0.3) 1.0 (ref) 1.0 (ref)
  Abnormal invasive placenta
CD 1st N (%) 131 (0.3) 1.14 (0.95 to 1.38) 1.00 (0.82 to 1.21)
VD 1st N (%) 672 (0.3) 1.0 (ref) 1.0 (ref)
  Uterine rupture
CD 1st N (%) 190 (0.4) 93.4 (51.9 to 166.9) 86.7 (48.2 to 156.1)
VD 1st N (%) 12 (0.005) 1.0 (ref) 1.0 (ref)
  Pre- eclampsia
CD 1st N (%) 1970 (4.6) 2.58 (2.44 to 2.72) 1.60 (1.51 to 1.70)
VD 1st N (%) 4609 (1.8) 1.0 (ref) 1.0 (ref)
Singleton deliveries during 1996–2015.
*308 (0.7%) deliveries with missing information on SGA in the caesarean group and 2000 (0.8%) in the vaginal group.
†Adjusted maternal age, birth year, pregnancy- related disorders (pre- eclampsia and diabetes), SGA and congenital anomalies, uterine 
rupture, placenta previa, placental abruption in first pregnancy and the studied outcome in the first pregnancy.
‡306 (0.7%) deliveries with missing information on GA in the caesarean group and 1958 (0.8%) in the vaginal group.
GA, gestational age; SGA, small for gestational age.
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several other studies.31–34 In a retrospective cohort study 
and meta- analysis published in 2015, the authors found 
an association between previous CD and the risk for ante-
partum stillbirth in the second pregnancy with a pooled 
HR 1.40 (95% CI 1.10 to 1.77),35 similar to our results.
Another systematic review and a meta- analysis published in 
2018 reported no clear association of mode of delivery with 
perinatal death comparing previous CD with previous VD,9 
as opposed to the results of the present study. However, this 
meta- analysis included only two studies with considerably 
smaller populations than the present study and in one of 
them, the estimated OR for perinatal death was 1.29 (95% 
CI 0.94 to 1.79),32 more in line with our study. Moreover, 
an older study not included in the meta- analysis but with a 
population of the same size as our study, found increased risk 
for perinatal death among children born by a mother with a 
previous CD compared with previous VD (RR 1.33, 95% CI 
1.10 to 1.62).36
We have not found other studies addressing the risk of 
cerebral palsy in deliveries following a previous CD.
Regarding the secondary outcomes, the increased risks of 
SGA, preterm birth, uterine rupture and several placental 
complications in the second delivery following a previous 
CD compared with a previous VD, are in line with other 
studies.10 13 32 37–42 Somewhat unexpected the proportion 
with abnormal invasive placenta did not differ between the 
two groups, which may partly be explained by the quality of 
this variable in the MBRN. Another explanation may be that 
our study was limited to adverse outcomes only in the second 
pregnancy, and studies have reported that abnormal invasive 
placenta is strongly associated with increasing numbers of 
CD performed.43 44
Interpretation
The findings regarding antepartum and total stillbirth, 
and perinatal death were all in the same direction, rela-
tively precise and in line with previous literature, indi-
cating that these findings are robust. The increased odds 
for cerebral palsy and the trend towards increased risk 
for early neonatal death were less robust. However, the 
number of infants with cerebral palsy was low, and the 
number of infants who died during delivery and in the 
neonatal period were even lower, and these findings 
should therefore be interpreted with caution.
The increased risk for any of the primary adverse outcomes 
in the second pregnancy may be due to placental compli-
cations, as indicated by the higher occurrence of infants 
born SGA, as well as a higher occurrence of placenta previa, 
placental abruption and pre- eclampsia compared with preg-
nancies without a previous CD. We speculate that the scar 
in the uterus after previous surgery may play a role in the 
development of such placental complications, for example, 
through suboptimal placental implantation in the following 
pregnancy. In addition, a scar in the uterus is a locus minoris 
resistentiae, increasing the risk for rupture of the uterus in 
the following pregnancies, as supported by the very high 
increased risk of uterine rupture associated with previous CD 
found in our study.
Moreover, it is well documented that placental pathology, 
placental abruption, pre- eclampsia, uterine rupture, preterm 
birth and being born SGA are all risk factors for cerebral 
palsy.45–47 These risk factors may be involved both in ante-
natal as well as in perinatal events, leading to an insult of the 
brain. The increased risk for cerebral palsy is also consistent 
with the lower Apgar score among infants born by mothers 
with a previous CD, compared with those whose mothers had 
a previous VD, found in our study.
The trend towards increased risk for early neonatal 
mortality may be consistent with increased risk for intra-
partum death. However, the risk for neonatal death was only 
slightly different between the groups, which may be reason-
able due to other causes of death later in the neonatal period 
rather than complications during the delivery. More studies 
are required to investigate if and how mode of delivery in the 
second pregnancy may have affected this outcome.
Implication
In this population- based study from Norway, the absolute risk 
for stillbirth, neonatal death and cerebral palsy in the second 
pregnancy was low, as were the absolute risk for the secondary 
outcomes. Nonetheless, the increased relative risk for these 
complications should be included in the discussion with 
parents regarding mode of delivery, both when the mother 
requests a CD in the absence of a clear medical indication as 
well as in cases when a VD is associated with increased relative, 
but low absolute risk for adverse outcome. If the increased 
risk was entirely related to the actual mode of delivery in the 
second pregnancy, it might be reasonable to recommend a 
planned CD to all women with a previous CD in their subse-
quent pregnancy. However, this would not abolish the risk for 
antepartum stillbirth, SGA and preterm birth. Therefore, the 
main prevention of these severe complications in subsequent 
pregnancy may be to take individual plans for further preg-
nancies into account when considering CD without a clear 
medical indication. On the other hand, it should be under-
scored that overall, the absolute risks for stillbirth, perinatal 
mortality and cerebral palsy after a previous CD are indeed 
low in the following pregnancy.
CONCLUSION
A previous CD was in this study associated with increased risk 
for stillbirth and perinatal death compared with a previous 
VD. Although less robust, we also found that a previous CD 
was associated with a slightly increased risk of cerebral palsy 
among children surviving the neonatal period. The aetiology 
behind these associations needs further investigation.
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